EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieVergleichsstudieOpen access · CC BY-NC-ND 4.0

Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial

Ajenthen G Ranjan iD, Christian Laugesen iD, Dimitri Boiroux, Signe Schmidt iD, Asbjørn T Reenberg, Jens Juul Holst iD, John B Jørgensen, Kirsten Nørgaard

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70577 ↗

At a glance

Randomisierte kontrollierte Studie in Diabetes, Obesity and Metabolism, 2026. Written by Ajenthen G Ranjan and 7 co-authors. Institution: Diabetes Technology Research, Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark. Major MEDLINE topics: Diabetes Mellitus, Type 1, Glucagon, Hypoglycemic Agents, Insulin. 25 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Danish Diabetes and Endocrine Academy.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims To assess the efficacy and safety of an automated insulin‐glucagon delivery system (AIGD) compared with an automated insulin delivery system (AID). Materials and methods In a 33‐h, randomised, crossover, inpatient study, 13 participants with type 1 diabetes used the DiaCon system in AIGD and AID modes. Each study period included two overnight stays and standardised challenges: receiving 50% of the calculated insulin bolus for breakfast, 100% bolus for lunch, 130% bolus for dinner, and a 45‐min unannounced bicycle exercise at 50% VO 2max . Co‐primary endpoints were (1) number of 15‐g carbohydrate treatments for plasma glucose 10.0 mmol/L (27.5 ± 14.8% vs. 29.2 ± 10.4%, p = 0.46) were similar. Mean glucose and coefficient of variation were comparable between AIGD versus AID ( p = 0.30). The post hoc analysis demonstrated that AIGD had significantly higher TIR 0–3 h after exercise and fewer hypoglycaemia events (

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1GlucagonHypoglycemic AgentsInsulinInsulin Infusion SystemsAdultFemaleHumansMaleMiddle AgedBlood GlucoseContinuous Glucose MonitoringCross-Over StudiesHypoglycemiaInpatientsSingle-Blind Method

Author keywords

continuous glucose monitoring (CGM)effectivenessglucagonglycaemic controlinsulin pumptherapytype 1 diabetes

Substances

Blood GlucoseGlucagonHypoglycemic AgentsInsulin

Authors and institutions

  • Diabetes Technology Research, Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Danish Diabetes Academy, Odense, Denmark.
  • Department of Applied Mathematics and Computer Science, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID profiles: Ajenthen G Ranjan, Christian Laugesen, Signe Schmidt, Jens Juul Holst

Funding

  • Danish Diabetes and Endocrine Academy

Cite

APA

Ranjan, A. G., Laugesen, C., Boiroux, D., Schmidt, S., Reenberg, A. T., Holst, J. J., Jørgensen, J. B., & Nørgaard, K. (2026). Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70577

Vancouver

Ranjan AG, Laugesen C, Boiroux D, Schmidt S, Reenberg AT, Holst JJ, et al. Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70577

BibTeX
@article{Ranjan2026,
  author = {Ranjan, Ajenthen G and Laugesen, Christian and Boiroux, Dimitri and Schmidt, Signe and Reenberg, Asbjørn T and Holst, Jens Juul and Jørgensen, John B and Nørgaard, Kirsten},
  title = {Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70577}
}
Start for free →